Rob Roovers

Company: Lava Therapeutics

Job title: Senior Director Preclinical Development

Seminars:

Describing the Identification & Preclinical Development of a Novel Bispecific Gamma-Delta T Cell Engager for Hematological Indications 11:00 am

Characterizing Vγ9δ2 T cells as a specific subset of T cells with innate immunity-like features, making them ideal effector cells for a T cell engager approach Demonstrating that the presence and frequency of these cells correlates with prognosis in patients suffering from different (hematological) malignancies Developing a single domain antibody panel against the semi-invariant Vgamma9Vdelta2…Read more

day: Day 1 am track a